Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS +20.00%·Rev n/aQ1 26EPS 0.00%·Rev n/aQ4 25EPS +9.09%·Rev n/aQ3 25EPS -100.00%*·Rev n/a⚠ consensus missing

CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV

Ryan — Investor Relations

Andrew Toy — Chief Executive Officer

Clay Thornton — Interim Chief Financial Officer

+2.8%1d on move date3d+4.2%5d+8.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLOV calls or request research access.

More CLOV calls Browse calls Request research access